Effect of Atorvastatin on Clinical Manifestations and Outcomes in Patients with COVID-۱۹
- سال انتشار: 1403
- محل انتشار: مجله علوم دارویی و شیمی، دوره: 7، شماره: 1
- کد COI اختصاصی: JR_JMCH-7-1_023
- زبان مقاله: انگلیسی
- تعداد مشاهده: 63
نویسندگان
Department of Anesthesiology and Critical Care, Arak University of Medical Sciences, Arak, Iran
Department of Infectious Disease, Arak University of Medical Sciences, Arak, Iran
Department of Anesthesiology and Critical Care, Arak University of Medical Sciences, Arak, Iran
Department of Cardiovascular Surgery, Arak University of Medical Science, Arak, Iran
Department of Cardiovascular Surgery, Arak University of Medical Science, Arak, Iran
چکیده
Background: Coronavirus disease ۲۰۱۹ (COVID-۱۹) caused by severe acute respiratory syndrome coronavirus ۲ (SARS-CoV۲) has been associated with severe respiratory disease incidence and increased morbidity and mortality of patients all over the world. The aim of this study is evaluation of Atorvastatin effect on patients with COVID-۱۹.Materials and methods: This is a prospective randomized controlled trial with ۱۰۰ adults diagnosed with COVID-۱۹. Participants randomly received Atorvastatin or just routine protocol of treatment for ۱۰ days. Primary outcomes are duration of fever and cough, atrial oxygen saturation (SPO۲), length of hospitalization and ICU stay, duration of oxygen therapy or intubation, and mortality rate. Secondary outcomes contain white blood cell count, lymphocyte percentage, lactate dehydrogenase, and creatine phosphokinase level.Results: There was no significant difference in age and sex between two groups. Atrial oxygen saturation (SPO۲) with/without non-invasive oxygen therapy was significantly higher in statin group (P=۰.۰۰۱, P=۰.۰۰۲, respectively). However, other primary and secondary outcomes was similar in both groups.Conclusion: Statin use was associated with higher percentage of SP۰۲, but there were no significant differences in other outcomes.کلیدواژه ها
Coronavirus disease (COVID, ۱۹) Atorvastatin Outcomes Mortalityاطلاعات بیشتر در مورد COI
COI مخفف عبارت CIVILICA Object Identifier به معنی شناسه سیویلیکا برای اسناد است. COI کدی است که مطابق محل انتشار، به مقالات کنفرانسها و ژورنالهای داخل کشور به هنگام نمایه سازی بر روی پایگاه استنادی سیویلیکا اختصاص می یابد.
کد COI به مفهوم کد ملی اسناد نمایه شده در سیویلیکا است و کدی یکتا و ثابت است و به همین دلیل همواره قابلیت استناد و پیگیری دارد.